US FDA approves first generic versions of Merck's Singulair
11:32 EDT 3 Aug 2012 | Reuters
WASHINGTON, Aug 3 (Reuters) - The U.S. Food and Drug Administration on Friday said it has approved the first generic versions of Merck & Co Inc's Singulair for use in adults and children to control asthma symptoms and relieve both indoor and outdoor..
Original Article: US FDA approves first generic versions of Merck's Singulair
More From BioPortfolio on "US FDA approves first generic versions of Merck's Singulair"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
